Home / Companies / Predictive Oncology Inc. / 25 Nov 2025
Predictive Oncology Inc.: meeting of 25 Nov 2025
Votes reported on Form N-PX, item by item
23 Form N-PX filers reported votes at the Predictive Oncology Inc. meeting of 25 Nov 2025. Their records fall into 1 item below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
29 vote records from 23 filers. 9 of the 20 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Say-on-pay |
|---|---|
| Vanguard | For |
| Fidelity | For |
| State Street and SPDR | For |
| Goldman Sachs | For |
| Northern Trust and FlexShares | Against * |
| SEI | Against * |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Predictive Oncology Inc. meeting?
23 Form N-PX filers reported votes at the meeting of 25 Nov 2025. On say-on-pay, 9 of 20 voted against management (45.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Predictive Oncology Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Predictive Oncology Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Predictive Oncology Inc. with a meeting date within three days of 25 Nov 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.